Comparing the high-dose dexamethasone effect versus prednisolone in treatment of immune thrombocytopenic purpura patients
Phase 3
Recruiting
- Conditions
- Immune thrombocytopenic purpura.
- Registration Number
- IRCT20211111053039N1
- Lead Sponsor
- Oroumia University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 36
Inclusion Criteria
Patients with ITP, which are newly diagnosed and have been treated and previously no therapies
Exclusion Criteria
People with life-threatening bleeding such as brain hemorrhage
People with trauma
People who have recent surgery
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Platelets count. Timepoint: daily. Method of measurement: complete blood count.
- Secondary Outcome Measures
Name Time Method